Results 1 to 10 of about 2,930,894 (275)

Immunoglobulin replacement therapy in secondary hypogammaglobulinemia [PDF]

open access: yesFrontiers in Immunology, 2014
Immunoglobulin (Ig) replacement therapy dramatically changed the clinical course of primary hypogammaglobulinemias, significantly reducing the incidence of infectious events.
Nicolò eCompagno   +3 more
doaj   +7 more sources

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy [PDF]

open access: yesFrontiers in Immunology, 2022
PurposeImmunoglobulin (Ig) replacement therapy is an important life-saving treatment modality for patients with primary antibody immune deficiency disorders (PAD).
Juan Marcos Gonzalez   +4 more
doaj   +6 more sources

Use of Immunoglobulin Replacement Therapy in Clinical Practice: A Review [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology
Immunoglobulins (Igs) are produced by B lymphocytes and play a key role in humoral immunity. Igs are classified into five isotypes (IgG, IgA, IgM, IgE, and IgD). Their primary function is to recognize and bind to foreign antigens.
Jibran Ahmed   +4 more
doaj   +4 more sources

To substitute or not? A systematic review of immunoglobulin replacement therapy in multiple myeloma patients treated with bispecific antibodies [PDF]

open access: yesFrontiers in Immunology
Bispecific antibodies are a novel class of immunotherapies that have demonstrated high response rates in heavily pretreated patients with multiple myeloma.
Juni Songe Paulsen   +4 more
doaj   +2 more sources

Immunoglobulin replacement therapy in antineutrophil cytoplasmic antibody-associated vasculitis with rituximab-associated hypogammaglobulinemia: infection outcomes and disease course in a retrospective cohort [PDF]

open access: yesFrontiers in Nephrology
ObjectiveTo evaluate whether immunoglobulin replacement therapy (IgR), initiated for infection prophylaxis in patients with ANCA-associated vasculitis (AAV) receiving rituximab, is associated with changes in infection burden, disease activity, and the ...
Matthew Gross   +4 more
doaj   +2 more sources

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID) [PDF]

open access: yesFrontiers in Immunology, 2023
IntroductionCommon variable immunodeficiency (CVID) is the most prevalent symptomatic primary immunodeficiency. CVID is a heterogeneous disorder with a presumed multifactorial etiology. Intravenous or subcutaneous immunoglobulin replacement therapy (IgRT)
Remo Poto   +24 more
doaj   +2 more sources

Effectiveness of immunoglobulin replacement therapy in preventing infections in patients with chronic obstructive pulmonary disease: a systematic review [PDF]

open access: yesAllergy, Asthma & Clinical Immunology
Purpose Immunoglobulin replacement therapy is a standard treatment for patients with antibody production deficiencies, which is of interest in patients with chronic obstructive pulmonary disease (COPD).
Justin J. Y. Kim   +5 more
doaj   +2 more sources

Current Practice and Perspectives on Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Antibody Deficiency Among Specialized Nurses in Poland [PDF]

open access: yesNursing Reports
Background/Objectives: Inborn errors of immunity (IEI) encompass various congenital disorders, resulting in immunity defects and recurrent infections. Home-based subcutaneous immunoglobulin replacement therapy (scIgRT) is the best treatment option for ...
Dorota Mizera   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy